Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials
BackgroundChronic coronary syndromes (CCS) is a common clinical condition that increases the risk of cardiovascular events at any time. Tongxinluo capsules (TXL) are widely used in China for treating CCS.ObjectivesTo systematically evaluate the therapeutic effects and safety of adding TXL to Western...
Saved in:
Main Authors: | Shi-Bing Liang, Yi-Fei Wang, Zhen-Chao Niu, Yu-Fei Li, Hui-Min Zheng, Jia-Ming Huan, Jie Yuan, Nicola Robinson, Jian-Ping Liu, Yun-Lun Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1499585/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HPGCN: A graph convolutional network-based prediction model for herbal heat/cold properties
by: Qikai Niu, et al.
Published: (2025-03-01) -
Study and optimization on system architectures of Larbin
by: Xuan WANG, et al.
Published: (2016-08-01) -
Implementation of shared file encrypted storage hierarchical access control scheme
by: Li LI, et al.
Published: (2016-07-01) -
Comparison of the Effects of Vitagnus, Soy, and Vitagnus-soy Capsules on Premenstrual Syndrome in University Students: A Randomized Clinical Trial
by: Roya Partovi Golshan, et al.
Published: (2025-01-01) -
From disease management to prevention, hip prosthesis joint infections in the past 20 years: a global research trends and top 10 cited articles analysis
by: Fei-Long Li, et al.
Published: (2025-01-01)